Eyenovia (EYEN)
(Delayed Data from NSDQ)
$0.56 USD
+0.07 (14.35%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $0.56 0.00 (-0.87%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Income Statements
Fiscal Year end for Eyenovia, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 14 | 2 | 0 |
Cost Of Goods | 0 | 0 | 2 | 1 | 0 |
Gross Profit | 0 | 0 | 12 | 1 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 25 | 27 | 25 | 21 | 21 |
Income After Depreciation & Amortization | -25 | -27 | -13 | -20 | -21 |
Non-Operating Income | 1 | 0 | 1 | 0 | 0 |
Interest Expense | 2 | 1 | 0 | 0 | 0 |
Pretax Income | -27 | -28 | -13 | -20 | -21 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -27 | -28 | -13 | -20 | -21 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -27 | -28 | -13 | -20 | -21 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -24 | -26 | -13 | -20 | -21 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -25 | -27 | -13 | -20 | -21 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 41.03 | 33.65 | 26.32 | 21.06 | 14.35 |
Diluted EPS Before Non-Recurring Items | -0.66 | -0.83 | -0.51 | -0.94 | -1.47 |
Diluted Net EPS (GAAP) | -0.66 | -0.83 | -0.49 | -0.94 | -1.47 |
Fiscal Year end for Eyenovia, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.49 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | -0.47 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 11.22 | 10.27 | 7.46 | 6.52 | 5.96 |
Income After SG&A, R&D, and Dept/Amort Expenses | -11.69 | -10.27 | -7.46 | -6.52 | -5.96 |
Non-Operating Income | 1.31 | 0.02 | 0.18 | -0.14 | 0.30 |
Interest Expense | 0.67 | 0.68 | 0.68 | 0.68 | 0.56 |
Pretax Income | -11.05 | -10.92 | -7.97 | -7.34 | -6.22 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -11.05 | -10.92 | -7.97 | -7.34 | -6.22 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -11.05 | -10.92 | -7.97 | -7.34 | -6.22 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 53.12 | 46.61 | 45.40 | 40.14 | 38.09 |
Diluted EPS Before Non-Recurring Items | -0.18 | -0.18 | -0.18 | -0.18 | -0.16 |
Diluted Net EPS (GAAP) | -0.21 | -0.23 | -0.17 | -0.18 | -0.16 |